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Abstract—Major depressive disorder (MDD) is characterized by severe affective as well as cognitive symptoms.
Moreover, cognitive impairment in MDD can persist after the remission of affective symptoms. Theta-burst stim-
ulation (TBS) is a promising tool to manage the affective symptoms of major depressive disorder (MDD); however,
its cognition-enhancing effects are sparsely investigated. Here, we aimed to examine whether the administration
of bilateral TBS has pro-cognitive effects in MDD. Ten daily sessions of neuronavigated active or sham TBS were
delivered bilaterally over the dorsolateral prefrontal cortex to patients with MDD. The n-back task and the attention
network task were administered to assess working memory and attention, respectively. Affective symptoms were
measured using the 21-item Hamilton Depression Rating Scale. We observed moderate evidence that the depres-
sive symptoms of patients receiving active TBS improved compared to participants in the sham stimulation. No
effects of TBS on attention and working memory were detected, supported by a moderate-to-strong level of evi-
dence. The effects of TBS on psychomotor processing speed should be further investigated. Bilateral TBS has a
substantial antidepressive effect with no immediate adverse effects on executive functions.  2021 The Author(s).
Published by Elsevier Ltd on behalf of IBRO. This is an open access article under the CC BY license (http://creativecommons.
org/licenses/by/4.0/).
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Repetitive transcranial magnetic stimulation (rTMS) is
now considered a therapeutic measure to reduce the
affective symptoms of major depressive disorder (MDD)
(see Lefaucheur et al., 2020 for review). Over the dorso-
lateral prefrontal cortex (DLPFC), both the left-
hemispheric, facilitatory rTMS (5 Hz or above, high-
frequency, HF-rTMS) (O’Reardon et al., 2007) and the
right-hemispheric, inhibitory stimulation (1 Hz, low- fre-
quency, LF-rTMS) are beneficial compared to sham stim-
ulation (Fitzgerald et al., 2003, 2009; Isenberg et al.,https://doi.org/10.1016/j.neuroscience.2021.03.001
0306-4522/ 2021 The Author(s). Published by Elsevier Ltd on behalf of IBRO.
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1302005; Stern et al., 2007). A patterned version of rTMS,
namely theta-burst stimulation (TBS), significantly
reduces the duration and cost of the stimulation and
seemingly exerts comparable effects to rTMS
(Blumberger et al., 2012; Mendlowitz et al., 2019;
Nyffeler et al., 2007; Zafar et al., 2008). The inhibitory pat-
tern of TBS is continuous TBS (cTBS), which applies an
uninterrupted train of bursts, and the facilitatory is inter-
mittent TBS (iTBS), which is fragmented by pauses
among the trains of bursts (Huang et al., 2005). TBS over
the DLPFC mitigates the clinical symptoms of MDD with
an effect estimation similar to rTMS (Li et al., 2014;
Plewnia et al., 2014; Schwippel et al., 2019; Williams
et al., 2018). In addition to unilateral stimulation, sequen-
tially applied left facilitatory and right inhibitory (bilateral
stimulation) by either rTMS or TBS appears to be similarly
effective (Berlim et al., 2013a, 2013b; Chen et al., 2014;
Cheng et al., 2016; O’Reardon et al., 2007). Bilateral pro-
tocols are based on the observations of interhemispheric
imbalance in MDD (Grimm et al., 2008; Hecht, 2010), the
resolution of which is suggested to improve affective/licenses/by/4.0/).
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sively on affective changes and did not consider other
characteristic symptoms of MDD, such as cognitive
impairment. Here, we aimed at exploring the effective-
ness of bilateral TBS on both the affective and cognitive
symptoms of MDD.
Cognitive symptoms, especially deficits of executive
functions including attention (Kaiser et al., 2015) and
working memory (Gärtner et al., 2018) as well as psy-
chomotor retardation (Gorwood et al., 2014), are often
present in MDD, further exacerbating the burden of dis-
ease. Moreover, the impairment of all these cognitive
domains may persist even after the remission of the affec-
tive symptoms (Nebes et al., 2003; Rock et al., 2014). The
effectiveness of pharmacotherapy appears to be limited to
some cognitive subdomains (Pan et al., 2017), while the
more promising results of rTMS are still preliminary and
inconclusive (Demirtas-Tatlidede et al., 2013; Iimori
et al., 2019; Martin et al., 2017) with reporting of no pro-
cognitive effect (Wajdik et al., 2014). Concerning TBS,
studies carried out on healthy participants revealed that
it might modulate cognition at behavioral (Lowe et al.,
2018; Vékony et al., 2018; Viejo-Sobera et al., 2017),
electrophysiological (Chung et al., 2017), and neuro-
chemical level (Suppa et al., 2016). Working memory
and attention can be enhanced even after one session
of TBS (He et al., 2013; Lowe et al., 2018; Xu et al.,
2013). However, differences are present across cognitive
domains, e.g., performance on tasks inquiring complex
executive functions appears not to be affected (Lowe
et al., 2018). Also, as the rationale of bilateral protocols
derives from the clinical characteristics of MDD patients,
the investigation of bilateral TBS in a preclinical setting
is limited. To date, only a few studies have assessed
whether TBS can mitigate cognitive impairment in MDD
(Cheng et al., 2016; Scho et al., 2019) and only an even
smaller proportion of these investigated bilateral TBS
(Cheng et al., 2016). The present randomized, sham-
controlled study aimed to examine the effects of 10 daily
bilateral TBS sessions on the clinical symptoms and
executive function in MDD. We assessed working mem-
ory and attention using standardized neurocognitive tests:
the n-back and the Attention Network Task (ANT). Overall
reaction times (RTs) for both tasks were also investigated
to gather information on psychomotor processing speed.
Since TBS effects on the working memory domain seem
to be the most reliable based on results of healthy partic-





Resting motor threshold (%) 6
HDRS at baseline 1
Benzodiazepine during treatment (number of patients) 3
Antidepressant during treatment (number of patients) 6
Antidepressant and benzodiazepine combined (number of patients) 1
Between group analyses were carried out using independent t-tests for continuous variabatric disorders (Demirtas-Tatlidede et al., 2013),
enhanced performance on the n-back task was expected.
As TBS is suggested to enhance attention (He et al.,
2013), we also expected improvements on the ANT. To
detect potential changes in clinical symptoms, the Hamil-
ton Depression Rating Scale (HDRS) was administered.
Classical statistical analysis was supplemented by Baye-
sian statistics to quantify the strength of the evidence.EXPERIMENTAL PROCEDURES
Participants
Patients diagnosed with unipolar MDD by experienced
physicians were recruited from the Department of
Psychiatry of the Albert Szent-Györgyi Health Centre,
University of Szeged. The diagnosis was established
based on DSM-IV criteria using the Structured Clinical
Interview for DSM-IV Axis I disorders. Patients with any
confounding conditions such as comorbid major
psychiatric disorders (e.g., substance abuse, psychosis)
and individuals with a history of neurological disorders
(e.g., stroke, epilepsy, head injury) were excluded.
Those who did not meet the safety restrictions of TBS
(e.g., having metallic implants in the cephalic region or
any implanted electronic devices) were excluded. Based
on a meta-analysis, pharmacotherapy might support the
development of more stable antidepressive effects
(Kedzior et al., 2012). Therefore, TBS was applied as
add-on therapy. Stable pharmacological status was
required from at least two weeks before the commence-
ment of the study and maintained throughout the TBS
therapy. All participants signed informed consent. The
experimental protocol was approved by the local Ethics
Committee of the University of Szeged in accordance with
the Declaration of Helsinki.
Overall, 25 participants have been recruited and
randomly assigned to receive either active or sham
stimulation. Three participants assigned to the sham
group withdrew participation before the completion of all
TBS sessions. Two additional participants were
excluded: one participant from the active TBS group
was excluded due to health concerns unrelated to TBS,
and one from the sham group who requested changes
in medication after reporting adverse effects. These
drop-outs were deemed to be at random. Analysis of
complete cases was carried out involving 20 participants
(Table 1).ing treatment and the subgroups (mean ± SD)
otal sample Subgroups
Active group Sham group p
/15 1/9 4/6 0.303
0.27 ± 13.24 51.86 ± 14.55 48.68 ± 12.35 0.605
9/1 9/1 10/0 0.352
0.6 ± 10.85 63.6 ± 10.59 57.6 ± 4.32 0.226
7.2 ± 5.4 19.5 ± 5.7 15.0 ± 4.3 0.062
1 2 1.000
2 4 0.628
1 7 4 0.370
les and Fisher’s exact tests for categorical variables.
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Participants were assigned to active or sham group using
computer-generated allocation on the day of baseline
testing, i.e., one workday before the commencement of
the 10-session stimulation protocol. Participants were
not aware of their group assignment. Baseline testing
involved: (1) the measurement of the resting motor
threshold (which was assessed to ensure the that
resting motor threshold was comparable between the
two groups) and (2) the administration of the HDRS, as
well as (3) the neurocognitive tests (the n-back and the
ANT). Subsequently, participants underwent 10
sessions of bilateral TBS delivered on consecutive
workdays. The HDRS and the neurocognitive tests were
then administered a second time, one day after the last
TBS session.Theta-burst stimulation protocol
Ten sessions of either active or sham stimulation were
delivered on consecutive workdays. This therapy length
is a frequent choice in treating MDD (e.g., Cheng et al.,
2016; Chistyakov et al., 2015). A Magstim Rapid2 stimula-
tor with a D702 70 mm figure-of-eight coil (The Magstim
Company Ltd, Whitland, Wales, UK) was used to gener-
ate TBS pulses. Before the start of TBS sessions, an
anatomical T1-weighted MRI scan was performed using
a 1.5T GE Signa Excite HDxt scanner (Milwaukee, WI,
USA) with the following setup: 3D IR-FSPGR - TR/TE/
TI: 10.3/4.1/450 ms; flip angle: 15; ASSET: 2, FOV:
25  25 cm; matrix: 256  256; slice thickness: 1 mm.
The MRI recordings were used to generate a 3D brain
model based on each participants’ gyral morphology to
localize the target area. The target area was localized at
Brodmann 9/46, involving the anterior third of the middle
frontal gyrus. This region is anatomically connected to
the subgenual anterior cingulate cortex (sgACC), a region
heavily involved in the pathophysiology of MDD (Drevets
et al., 2008; Wu et al., 2016). Moreover, previous findings
have indicated an anticorrelation between the functional
connectivity of the Brodmann 9 and 46 regions and the
sgACC, the targeted modulation of which is associated
with higher TMS treatment efficacy (Fox et al., 2012). Pre-
cise coil positioning was supported by a TMS Neuronavi-
gator (Brain Innovation, Maastricht, the Netherlands) with
ultrasound CMS20 Measuring System (Zebris GmbH,
Tübingen, Germany). This TMS localization method is
suggested to require a smaller number of participants
while resulting in behavioral changes (Sack et al., 2008).
Each session involved cTBS over the right DLPFC
first, and then iTBS over the left DLPFC with a 25-
minute pause between the stimulation of the two sites.
The applied parameters were based on Huang et al.
(2005). cTBS contained 600 uninterrupted pulses given
for 40 s (with a pattern of 3 pulses at 50 Hz in every
200 ms). The number of pulses was identical during iTBS,
but the pattern consisted of 3 pulses in a train of 2 s given
at 50 Hz, repeated every 10 s for 40 trains. The stimula-
tion intensity was set at 30% of the maximal stimulator
output for all participants. The stimulation intensity was
kept constant, as suggested by Kaminski et al. (2011)because motor and visual cortex excitability appears to
be independent, which indicates that cortical excitability
of other brain areas may not be related either
(Boroojerdi et al., 2002). The chosen intensity of 30%
was comparable with the average intensity of other TBS
studies involving healthy participants (Lowe et al.,
2018). Similar intensities also resulted in behavioral
changes in MDD patients (Li et al., 2014). In addition,
recent preliminary results also supported the beneficial
effects of subthreshold TBS on depressive symptoms in
a substantial proportion of MDD patients (Halper et al.,
2019). The protocol for patients in the sham group was
identical to the active stimulation, but a plastic block ele-
vated the coil from the scalp by 4 cm. Therefore, the par-
ticipants still experienced some mechanical vibration and
heard the clicking sounds of the device without significant
cortical stimulation. To ensure that cortical excitability was
comparable between the two groups, the resting motor
threshold (rMT) was determined with the visualization
method on the day of baseline testing (Pridmore et al.,
1998). This procedure is found to reliably measure cortical
excitability (Varnava et al., 2011).Testing of affective symptoms
The primary outcome measure of clinical symptoms was
the change of depressive symptoms measured by the
21-item Hamilton Depression Rating Scale. HDRS is a
half-structured interview widely used in clinical research
(Behera et al., 2017). The HDRS involves the evaluation
of a range of depression-related symptoms, including
affective state, suicidal thoughts, somatic symptoms,
sleeping and eating behavior, and sexual symptoms
(Hamilton, 1960).N-back task
Working memory was tested with the n-back task (Sweet,
2011). One-, two- and three-back tasks were adminis-
tered consecutively using PsychoPy (version: v1.82.01).
At each level, stimuli selected from a set of capital letters
(A, C, E, I, K, L, S, O, R, T, U) were presented succes-
sively in the middle of the screen. Stimuli were presented
for 1500 ms with 500-ms-long interstimulus intervals. For
the 1-back task, participants had to press the spacebar if
the currently appearing stimulus was the same as the pre-
vious one. For the 2-back and 3-back tasks, the spacebar
had to be pressed if the second (2-back) or third letter (3-
back) prior to the current stimulus was identical to the cur-
rent stimulus. At each level, a total of 100 trials were com-
pleted and 20% of all presented stimuli were target stimuli
to which participants were expected to respond. Based on
the signal detection theory, we calculated d’ as an index of
sensitivity and performance. d’ was defined as the sub-
traction of the hit rate and the false alarm rate expressed
in z-scores domain (Haatveit et al., 2010):
d0 ¼ Z hit rateð Þ  Z false alarm rateð Þ
Performance on the 1-back task was analyzed in the
attention domain, while outcomes of the 2-back and 3-
back tasks were averaged and examined in the working
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were calculated.Attention network task
The ANT described by Fan et al. (2002) was administered
to evaluate attention processes. First, a fixation cross
appeared in the middle of the screen for a random dura-
tion between 400 and 1600 ms. Then, a 100-ms-long
cue may or may not appear, preceding the target stimu-
lus. Three types of cue were possible: (1) spatial cue indi-
cating the position where the target stimulus was
presented (2) center cue appearing in the position of the
fixation cross (3) double cue presented both above and
below the position of the fixation cross. If no cue appeared
or the cue had already disappeared, the fixation cross
was reintroduced for 400 ms. The stimuli included a target
arrow pointing to the left or right to which participants had
to respond by pressing the corresponding arrow button on
the keyboard. One of the following types of stimuli were
presented randomly: (1) in the neutral condition, target
stimuli contained four lines and the target arrow in the
middle (2) the congruent condition contained five arrows
pointing to the same direction (3) the incongruent condi-
tion contained four arrows pointing to the same direction
and the target arrow in the middle pointing to the opposite
way. Stimuli were presented until a response (with a max-
imum presentation time of 1700 ms), after which a blank
screen was presented for the remaining duration. Overall,
one trial lasted for 3500 ms, and 300 trials were pre-
sented, comprising 24 practice trials and three blocks of
96 trials.
Median RTs of the correct trials were used to
formulate three indices that measured different
attentional subnetworks. The alerting attention ratio
measures how one can achieve and maintain an alert
state. The orienting attention ratio describes the ability
to select relevant information from the sensory input.
The executive attention ratio refers to the ability to
resolve conflict among responses. All indices were
corrected to the relevant baseline RTs. For alertness
and orientation, a higher ratio indicates better attentional
processing. On the contrary, a higher executive
attention ratio indicates less effectiveness in dealing
with interference. For an estimate of psychomotor
speed, median RTs across all cue and target conditions
were calculated. The indices were calculated as follows:
alerting attention ratio ¼ ðRTdouble cue  RTno cue Þ=RTno cue
orienting attention ratio ¼ ðRTspatial cue  RTcenter cueÞ=RTcenter cue
executiveattention ratio ¼ RTincongruent  RTcongruent
 
=RTcongruentStatistical analysis
Statistical analysis was conducted using SPSS version 24
(IBM SPSS Statistics for Windows, 2016). Age, sex, rMT,
handedness, and medication status before the first TBS
session were compared between groups using
independent t-tests for continuous variables andFisher’s exact tests for categorical variables. Difference
scores between baseline and post-TBS HDRS
(HDRSpre-TBS – HDRSpost-TBS) were compared using an
independent samples t-test. Cohen’s d was reported as
an index of effect size. Moreover, difference scores
were entered into an analysis of covariance (ANCOVA)
with pre-TBS HDRS score used as a covariate to
examine whether baseline scores influence the results.
For the n-back task, d’ measures of 1-back
(interpreted as a measure of attentional processes) and
the average of the d’s for the 2-back and 3-back tasks
(interpreted as a measure of working memory) were
analyzed using separate 2  2 mixed analyses of
variance (ANOVAs) with TIME (pre-TBS vs. post-TBS)
as a within-subject factor and the type of STIMULATION
(active vs. sham) as a grouping variable. For ANT,
alertness, orientation, and executive attention ratios
were entered separately into 2  2 mixed ANOVAs with
TIME (pre-TBS vs. post-TBS) as a within-subject factor
and the type of STIMULATION (active, sham) as the
grouping variable. Effect sizes for each ANOVA were
estimated using partial eta squared (gp
2), and Bonferroni
correction was applied to correct for multiple
comparisons.
Bayesian statistics were performed using JASP
(0.12.2.0 version) (JASP Team, 2020) with default
priors. The Bayesian approach can supplement the
frequentist approach by providing an estimate of
evidence strength. Bayesian analyses quantify the
relative evidence in favor of the null (H0) or alternative
hypothesis (H1) based on the collected data. We
calculated and reported the BF10, which is primarily a
continuous measure; however, it was interpreted based
on the following approximate classification scheme:
BF10 < 0.1 indicates strong evidence for H0, a value
between 0.1 and 0.33 indicates substantial evidence for
H0, while a value between 0.33 and 1 indicates
anecdotal evidence for H0. Anecdotal evidence supports
H1 if BF10 is between 1 and 3, a value between 3 and
10 indicates substantial evidence for H1, and BF10 > 10
indicates strong evidence for H1 (Wagenmakers et al.,
2018). To make our results more easily interpretable,
we report the BF01 results (1 divided by BF10) when evi-
dence supports the H0. For the Bayesian ANOVAs, the
inclusion Bayes Factor (BFincl) across matched models
is also reported. It quantifies the relative difference
between models containing the examined effect and the
equivalent models that do not contain it. BFincl is calcu-
lated by dividing the sum of the probabilities of the
observed data by the sum of the updated probabilities.RESULTS
Sample characteristics
The active and sham groups were comparable
concerning sex, age, handedness, resting motor
threshold, baseline HDRS score and medication status
(see Table 1). Concomitant antidepressant medication
of the participants was: venlafaxine (n= 4), mirtazapine
(n= 5), escitalopram (n= 2), duloxetine (n= 1),
clomipramine (n= 1), fluoxetine (n= 1), paroxetine
134 A. Holczer et al. / Neuroscience 461 (2021) 130–139(n= 1), maprotiline (n= 2) and agomelatine (n= 1).
Three participants received benzodiazepine treatment,
while two participants were prescribed more than one
antidepressants.
TBS effects on affective symptoms
A significant effect of TBS was found in the difference
scores of HDRS (HDRSpre-TBS – HDRSpost-TBS) between
the active and sham group, t18 = 2.522, p= .021,
Cohen’s d= 1.128. In light of the collected data,
Bayesian analysis indicated moderate evidence for a
difference between the change of HDRS scores,
BF10 = 3.028. Based on our results, the data was 3
times more likely under H1 (i.e., TBS treatment results
in affective changes in the active group) than H0 (i.e.,
TBS does not affect affective symptoms)
(Supplementary Material S1). Fig. 1(A) shows that a
higher reduction of HDRS scores was observed in
participants receiving active TBS (mean ± SE scores:
active group 8.2 ± 3.360; sham group 4.2 ± 1.172).Fig. 1. Cognitive and affective changes in the active and sham group. (A)
data points depicting the changes of HDRS difference scores (HDRSpre-TB
Box plot with individual data points depicting the reaction time changes on t
Table 2. Model comparison results of Bayesian mixed-model ANOVA
Models P(M) P(M
Null model 0.250 0.14
Type of stimulation 0.250 0.43
Type of stimulation + baseline HDRS 0.250 0.26
Baseline HDRS 0.250 0.15
P(M): prior model probabilities, P(M|data): updated probabilities, BFM: the degree change o
of H1ANCOVA controlling for baseline HDRS scores
indicated that the effect of baseline HDRS was not
significant, F1, 17 = 1.118, p= .305, gp
2 = 0.062,
BFincl = 0.726, whereas a tendency towards the effect
of stimulation type on HDRS scores persisted, F1,
17 = 3.415, p= .082, gp
2 = 0.167, BFincl = 2.372. The
Bayesian model comparison yielded that the best model
only included the type of stimulation, but not the
covariate. Moderate evidence (BF10 = 3.028) indicated
that this model should be chosen over the null model
(see Table 2).
For the RTs of the 1-back task, significant
TIME  STIMULATION interaction was found, F1,
18 = 7.503, p= .013, gp
2 = 0.294, BFincl = 4.501.
Pairwise comparisons revealed that the RTs of the
active TBS group decreased significantly compared to
the sham group, p= .031. There was a significant
difference between the active and the sham group at
the post-TBS time point, p= .046, while no difference
was present at the pre-TBS time point, p> .05. TheBox plot with individual







f the prior model odds after hRTs of the active group dropped
from (mean ± SE) 592.5 ± 45.3 to
524.5 ± 31.7, while the RTs of the
sham group increased from 575.8
± 45.38 to 620.7 ± 31.7 (Fig. 1
(B)). The main effect of TIME, F1,
18 = 0.318, p= .580, gp
2 = 0.017,
BFincl = 0.335, and STIMULATION,
F1, 18 = 0.597, p= .450,
gp
2 = 0.032, BFincl = 0.595, were
not significant. The Bayesian
analysis revealed that the null
model slightly outpredicted the full
model (BF10 = 0.908,
BF01 = 1.101), indicating
inconclusive evidence for the null
model (Supplementary Material S2).
Regarding the d’ scores of the 1-
back task, the main effect of TIME,
F1, 18 = 0.051, p= .824,
gp
2 = 0.003, BFincl = 0.312,
STIMULATION, F1, 18 = 1.803,
p= .196, gp
2 = 0.091,
BFincl = 0.806, and the
TIME  STIMULATION interaction,
F1, 18 = 0.006, p= .939,
gp
2 < 0.001, BFincl = 0.381, was not
statistically significant. The null
model was the best-fitting model,
i.e., it outperformed the full model
of BF10 = 0.095, BF01 = 10.476.





aving observed the data, BF10: Bayes Factor in favor
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evidence supporting the preference of the null model
(Supplementary Material S3).
The average of the average RTs of the 2-back and 3-
back tasks were entered into a mixed ANOVA which
yielded a non-significant main effect of TIME, F1,
18 = 0.520, p= .480, gp
2 = 0.028, BFincl = 0.396, and
STIMULATION, F1, 18 = 1.798, p= .197, gp
2 = 0.091,
BFincl = 0.710. The TIME  STIMULATION interaction,
F1, 18 = 1.422, p= .249, gp
2 = 0.073, BFincl = 0.630,
was not significant either. The null model was the best
model outperforming the full model of BF10 = 0.180,
BF01 = 5.556. The data were 5 times less likely to be
observed under H1 than under H0. This evidence
substantially supports that the null model should be
preferred (Supplementary Material S4).
Considering the d’ scores of the averaged 2-back and
3-back tasks, the main effect of TIME, F1, 18 = 2.078,
p= .167, gp
2 = 0.104, BFincl = 0.712, STIMULATION,
F1, 18 = 0.098, p= .758, gp
2 = 0.005, BFincl = 0.447,
and TIME  STIMULATION interaction, F1, 18 = 0.321,
p= .578, gp
2 = 0.018, BFincl = 0.433, was not
significant. Bayesian analysis indicated that the best-
fitting model was the null model. The results were 7
times less likely to be observed under H1 compared to
H0 which is considered as a substantial weight of
evidence supporting that the null model should be
preferred over the full model, BF10 = 0.146,
BF01 = 6.828 (Supplementary Material S5).
Attention network task
The mixed ANOVA of the overall RTs yielded that the
main effect of TIME, F1, 18 = 3.071, p= .097,
gp
2 = 0.146, BFincl = 0.908, the main effect of
STIMULATION, F1, 18 = 0.584, p= .455, gp
2 = 0.031,
BFincl = 0.551, and the TIME  STIMULATION
interaction, F1, 18 = 2.138, p= .161, gp
2 = 0.106,
BFincl = 1.164, were non-significant. The null model
outpredicted the full model (BF10 = 0.501,
BF01 = 1.995); however, the data were  2 times less
likely to be observed under H1 compared to H0 which
only indicates anecdotal evidence in support of the null
model (Supplementary Material S6).
Results on the alerting attention ratio indicated a non-
significant main effect of TIME, F1, 18 = 0.001, p= .973,
gp
2 < 0.001, BFincl = 0.306, STIMULATION, F1,
18 = 0.233, p= .635, gp
2 = 0.013, BFincl = 0.463, and a
non-significant interaction of TIME  STIMULATION, F1,
18 = 0.767, p= .393, gp
2 = 0.041, BFincl = 0.500. The
full model (BF10 = 0.073, BF01 = 13.718) was
outpredicted by the null model. Strong evidence
supported the preference of the null model as the data
were 14 times less likely to be observed under H1
than under H0 (Supplementary Material S7).
Regarding the orientating attention ratio, we found
that the main effect of TIME, F1, 18 = 0.961, p= .340,
gp
2 = 0.051, BFincl = 0.495, the main effect of
STIMULATION, F1, 18 = 0.576, p= .458, gp
2 = 0.031,
BFincl = 0.450, and the TIME  STIMULATION
interaction, F1, 18 = 0.173, p= .682, gp
2 = 0.010,
BFincl = 0.430, were not significant. The full model,BF10 = 0.095, BF01 = 10.545, was outperformed by the
null model. The likelihood of the data being observed
under H1 was 10 times less likely than under H0
indicating a strong evidence for the null model
(Supplementary Material S8).
The mixed ANOVA of the executive attention ratio
revealed a non-significant main effect of TIME, F1,
18 = 0.336, p= .570, gp
2 = 0.018, BFincl = 0.378,
STIMULATION, F1, 18 = 3.320, p= .085, gp
2 = 0.156,
BFincl = 0.581, and a non-significant interaction of
TIME  STIMULATION, F1, 18 = 0.017, p= .897,
gp
2 < 0.001, BFincl = 0.373. The full model
(BF10 = 0.083, BF01 = 12.042) was outperformed by
the null model i.e. its interpretation is limited. Compared
to H0, the likelihood of the data being observed under
H1 was 12 times lower indicating strong evidence
favoring null model (Supplementary Material S9).DISCUSSION
Therapeutic effects of rTMS over the DLPFC on
depressive symptoms are steadily gaining recognition.
Our results of improved affective symptoms in this
randomized, sham-controlled study after ten sessions of
bilateral TBS (cTBS over the right DLPFC+ iTBS over
the left DLPFC) support this notion. Bayesian analysis
further corroborated the presence of substantial
evidence in support of the antidepressive effects of
TBS. However, targeting DLPFC – which is a widely
preferred region for non-invasive brain stimulation
(Holczer et al., 2020) and a strongly implicated area in
MDD (Fitzgerald et al., 2008; Grimm et al., 2008) – might
not only affect the affective symptoms but also the cogni-
tive functioning (Diener et al., 2012). Strikingly, the cogni-
tive effects of NIBS in MDD are rarely investigated with
inconclusive preliminary results ranging from no effect
(Wajdik et al., 2014) to limited efficacy in some subdo-
mains (Iimori et al., 2019; Martin et al., 2017; Scho
et al., 2019). Our results indicate that TBS has no or lim-
ited effects on the working memory and attentional
domains.
The only cognitive measurement on which we found a
potential effect of TBS was the overall RT of the 1-back
tasks. After active TBS, the frequentist analysis
suggested an RT decrease similar to the practice effects
experienced in healthy participants (Soveri et al., 2018).
On the contrary, in the sham group, pre-TBS and post-
TBS RTs were comparable. The perceived shortening of
RTs independently of the cognitive load may occur due
to improved psychomotor processing speed. Psychomo-
tor speed is often slower in MDD compared to healthy
individuals (Liu et al., 2019; Semkovska et al., 2019;
Tian et al., 2016) and is associated with reduced cerebral
blood flow in the motor cortex in MDD (Yin et al., 2018).
However, the Bayesian analysis indicated inconclusive
results regarding the reaction time measures of the ANT
and the 1-back tasks. Thus, more investigations are
required to further verify this finding.
The improvement of psychomotor speed, if replicable,
might stem from the fact that TBS effects are propagated
to remote brain areas (Singh et al., 2020; Tang et al.,
136 A. Holczer et al. / Neuroscience 461 (2021) 130–1392015). Furthermore, TBS may modulate motor cortex
excitability (Cao et al., 2018) and cerebral blood flow
(Cho et al., 2012). Another possible explanation can be
that TBS might reduce frontal alpha asymmetry
(Pellicciari et al., 2017), which is linked to psychomotor
retardation (Cantisani et al., 2015).
More pronounced cognitive changes after TBS were
hypothesized as single-session stimulation with identical
protocols to ours resulted in TBS-induced theta power
modulation (Chung et al., 2017). Although theta power
increase is associated with improved working memory
performance (Jensen and Tesche, 2002; Lisman, 2010)
and cognitive control (Cavanagh and Frank, 2014), in
our study, TBS did not lead to such cognitive enhance-
ment. This result is in contrast with previous promising
results (Cheng et al., 2016; Scho et al., 2019). However,
in the study of Cheng et al. (2016), patients with
treatment-resistant depression were recruited, and a
higher dose of stimulation with 1800 pulses/session were
delivered. Scho et al. (2019) who have found improved
working memory performance, administered unilateral
TBS to the left DLPFC. Higher doses of TBS have been
proposed to exert more pronounced effects (Nettekoven
et al., 2014); however, other results have not fully sup-
ported this notion (Volz et al., 2013; Williams et al.,
2018). Therefore, it is not clear whether the differences
across results can be attributed to the difference in dosing
TBS or other factors such as sample characteristics. It is
also possible that the antidepressive and cognition-
enhancing effects of TBS might be independent.
In the present study, several methodological decisions
were based on reports of enhanced antidepressant
effects (in the lack of similar methodological
recommendations on enhancing cognition). For
example, TBS was administered as add-on therapy,
since concomitant pharmacotherapy might enhance the
development of more stable TBS effects on depressive
symptoms (Kedzior et al., 2012). However, cognition
and affective symptoms might benefit from different stim-
ulation parameters. Distinct patterns of metabolic
changes may follow iTBS, cTBS and bilateral TBS (Li
et al., 2018). Some TBS effects affecting regions outside
the DLPFC relevant to the implementation of executive
function (e.g., the medial prefrontal cortex and ACC for
cognitive control (Alexander and Brown, 2011)) may be
canceled out after bilateral TBS (Li et al., 2018). Thus, it
is possible that iTBS, but not the combination of iTBS
and cTBS might improve executive functions (Cheng
et al., 2016).
One limitation of the present study includes the sham
method chosen. While elevating the coil from the scalp
hinders significant cortical stimulation (Siebner et al.,
2009), other characteristic experiences such as scalp
sensations and peripheral nerve stimulation are mostly
abolished as well. Although the clicking sounds of the
machine and some mechanical vibration can be experi-
enced, the use of a more sophisticated sham method
(e.g., a sham coil that produces shallow magnetic fields
or weak electrical currents) would further improve the
blinding of the participants.Of note, our results may be slightly underpowered in
some cognitive domains, as indicated by the BFincl
values. However, BFincl values should be interpreted as
a continuous measure (Wagenmakers et al., 2018), and
for the ANT indexes and the d’ scores of the n-back task,
BFincl values of the interactions approached the cut-off
score. This indicates that the conclusions drawn are less
likely to be misleading regarding executive functions.
Importantly, we did not find evidence for any
immediate cognitive adverse effects of TBS. In
comparison, electroconvulsive therapy is associated
with impaired executive functioning, episodic memory
deficit, and deterioration of global cognition (Andrade
et al., 2016; Ren et al., 2014) that reverse in a few months
(Bodnar et al., 2016), we show that TBS has the advan-
tage of not causing similar temporary impairments while
exerting antidepressive effects in patients with MDD.
Taken together, the present study suggests that 10
sessions of bilateral TBS have evident antidepressive
effects but have limited cognition-enhancing efficacy.
We found that executive functions were not affected by
TBS. Hence, TBS might be a good alternative to
electroconvulsive therapy as it does not cause transitory
cognitive impairment. However, a systematic
comparison of the antidepressant and pro-cognitive
features (including the magnitude and the duration of
the effects) of different brain stimulation paradigms is
necessary. Further research is encouraged on the
effects of TBS regarding psychomotor speed, as our
results suggested a potential effect of TBS on RTs for
visual stimuli. Several questions are yet to be answered
regarding the optimal parameters of TBS and whether
antidepressant and cognitive-enhancing effects require
different parameters; thus, comparative studies of
bilateral and unilateral stimulation are warranted.
Nevertheless, bilateral TBS seems to be an acceptable
add-on therapy with promising antidepressant effects, a
possible effect on psychomotor speed, and no adverse
effects impacting attention or working memory.FUNDING
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